GALLIUM GA 68 GOZETOTIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gallium Ga 68 Gozetotide, and what generic alternatives are available?
Gallium Ga 68 Gozetotide is a drug marketed by Univ Ca Los Angeles and Univ Of Ca San Fran and is included in two NDAs.
The generic ingredient in GALLIUM GA 68 GOZETOTIDE is gallium ga-68 gozetotide. There are sixteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the gallium ga-68 gozetotide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GALLIUM GA 68 GOZETOTIDE?
- What are the global sales for GALLIUM GA 68 GOZETOTIDE?
- What is Average Wholesale Price for GALLIUM GA 68 GOZETOTIDE?
Summary for GALLIUM GA 68 GOZETOTIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 4 |
| DailyMed Link: | GALLIUM GA 68 GOZETOTIDE at DailyMed |
Recent Clinical Trials for GALLIUM GA 68 GOZETOTIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Novartis Pharmaceuticals | Phase 3 |
| Mayo Clinic | Phase 3 |
| Eli Lilly and Company | Phase 1/Phase 2 |
Pharmacology for GALLIUM GA 68 GOZETOTIDE
| Drug Class | Radioactive Diagnostic Agent |
| Mechanism of Action | Positron Emitting Activity |
US Patents and Regulatory Information for GALLIUM GA 68 GOZETOTIDE
GALLIUM GA 68 GOZETOTIDE is protected by zero US patents and two FDA Regulatory Exclusivities.
FDA Regulatory Exclusivity protecting GALLIUM GA 68 GOZETOTIDE
EXCLUSIVITY ON THIS APPLICATION EXPIRING ON THIS DATE HAS BEEN WAIVED BY SPONSOR - SEE SECTION 1.8 OF ORANGE BOOK PREFACE WAIVED EXCLUSIVITY
Exclusivity Expiration: ⤷ Sign Up
NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univ Ca Los Angeles | GALLIUM GA 68 GOZETOTIDE | gallium ga-68 gozetotide | SOLUTION;INTRAVENOUS | 212642-001 | Dec 1, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Univ Of Ca San Fran | GALLIUM GA 68 GOZETOTIDE | gallium ga-68 gozetotide | SOLUTION;INTRAVENOUS | 212643-001 | Dec 1, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
